TheEdgeResearch
Home / Stocks / BEAT

HeartBeam, Inc. (BEAT)

NASDAQ Healthcare Medical - Equipment & Services
$0.57 ▼ -2.73%
Market Cap
$31.7M
Sector
Healthcare
Industry
Medical - Equipment & Services
Beta
-0.79
52-Wk Range
0.481-4
CEO
Robert Eno
Country
US
Currency
USD

HeartBeam, Inc. operates in the Medical - Equipment & Services industry of the Healthcare sector, headquartered in Santa Clara, CA, US. The stock last traded at $0.57, down 2.73% on the session, giving a market capitalisation of $31.7M. On trailing twelve-month figures it carries a trailing P/E of -1.00, a net margin of 0.0%. Its beta of -0.79 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-1.00
Price / Sales
0.00
Price / Book
36.50
EV / EBITDA
-1.47
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.74
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
17
IPO date
2021-11-16
Headquarters
Santa Clara, CA, US
About HeartBeam, Inc.

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Comparable companies

HeartBeam, Inc. is most often compared with the following Healthcare names:

CRVOEQHOWLINKTIOBTMDAIONMDOSTXOTLKSPRB
More research on BEAT
BEAT technical analysis BEAT TheEdge Score Compare against peers
Open full interactive analysis & DCF →